INSR |
INSR: Insulin receptor precursor |
PKMYT1 |
PKMYT1, MYT1: Membrane-associated tyrosine- and threonine-specific cdc2-inhibito |
1.17 |
Evidence |
|
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
NR4A2 |
NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 |
1.17 |
Evidence |
|
CHRM2 |
CHRM2: Muscarinic acetylcholine receptor M2 |
TAGLN |
TAGLN, SM22, WS3-10: Transgelin |
1.17 |
Evidence |
|
STAM2 |
STAM2: Signal transducing adapter molecule 2 |
HES1 |
HES1, HL, HRY: Transcription factor HES-1 |
1.17 |
Evidence |
|
CSPG4 |
CSPG4, MCSP: Chondroitin sulfate proteoglycan 4 precursor |
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
1.17 |
Evidence |
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
HSP90AA1 |
Hsp89-alpha-delta-N |
1.17 |
Evidence |
|
INSR |
INSR: Insulin receptor precursor |
RPS3 |
RPS3, OK/SW-cl.26: 40S ribosomal protein S3 |
1.17 |
Evidence |
|
CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
1.17 |
Evidence |
|
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
NKX2-5 |
NKX2-5, CSX, NKX2.5, NKX2E: Homeobox protein Nkx-2.5 |
1.17 |
Evidence |
|
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
MAP2K6 |
MAP2K6, MEK6, MKK6, PRKMK6: Dual specificity mitogen-activated protein kinase ki |
1.17 |
Evidence |
|
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
ELK1 |
ELK1: ETS domain-containing protein Elk-1 |
1.17 |
Evidence |
|
SERPINC1 |
SERPINC1, AT3, PRO0309: Antithrombin-III precursor |
ITGA2B |
ITGA2B, GP2B, ITGAB: Integrin alpha-IIb precursor |
1.17 |
Evidence |
|
CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
GMIP |
GMIP: GEM-interacting protein |
1.17 |
Evidence |
|
GNAT2 |
GNAT2, GNATC: Guanine nucleotide-binding protein G(t), alpha-2 subunit |
HTR2C |
HTR2C, HTR1C: 5-hydroxytryptamine receptor 2C |
1.17 |
Evidence |
|
NCK2 |
NCK2: Cytoplasmic protein NCK2 |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
1.17 |
Evidence |
|
FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
RIN1 |
RIN1: Ras and Rab interactor 1 |
1.17 |
Evidence |
|
GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
PTGIR |
PTGIR, PRIPR: Prostacyclin receptor |
1.17 |
Evidence |
|
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
TXK |
TXK, PTK4: Tyrosine-protein kinase TXK |
1.17 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
FRK |
FRK, PTK5, RAK: Tyrosine-protein kinase FRK |
1.17 |
Evidence |
|
MAPK12 |
MAPK12, ERK6, SAPK3: Mitogen-activated protein kinase 12 |
SSH1 |
SSH1, KIAA1298, SSH1L: Protein phosphatase Slingshot homolog 1 |
1.17 |
Evidence |
|
BCKDHA |
BCKDHA: 2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial precursor |
PDK1 |
PDK1: [Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial precu |
1.17 |
Evidence |
|
GNA11 |
GNA11, GA11: Guanine nucleotide-binding protein subunit alpha-11 |
TSHR |
IPI00386365 |
1.17 |
Evidence |
|
MYCN |
MYCN, NMYC: N-myc proto-oncogene protein |
TCF3 |
TCF3, E2A, ITF1: Transcription factor E2-alpha |
1.17 |
Evidence |
|
PTK2 |
PTK2, FAK, FAK1: Focal adhesion kinase 1 |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
1.17 |
Evidence |
|
KCNA2 |
KCNA2: Potassium voltage-gated channel subfamily A member 2 |
RYR1 |
|
1.17 |
Evidence |
|